Clinical Trials Directory

Trials / Completed

CompletedNCT03513835

Diagnostic Screening Tests and Potential Biomarkers in Mitochondrial Myopathies

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to develop simple diagnostic screeningtests and investigate potential biomarkers for identifying patients with abnormalities of mitochondrial function, which also can be used as outcome measures in future clinical trials. The study will investigate two submaximal tests: a submaximal handgrip test and a walking test. Furthermore investigators will investigate Acyl-carnitine profiles and GDF-15 levels in patients with mitochondrial myopathy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDiagnostic screenings testsHandgrip test, 12-minute walk test and 6-minute walk test. Biomarkers: acyl-carnitine profile and GDF-15.

Timeline

Start date
2018-01-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2018-05-02
Last updated
2023-02-14

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03513835. Inclusion in this directory is not an endorsement.

Diagnostic Screening Tests and Potential Biomarkers in Mitochondrial Myopathies (NCT03513835) · Clinical Trials Directory